IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.380
-0.010 (-0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
IGM Biosciences Analyst Ratings
Total Analysts
8
Consensus Rating
Hold
Price Target
$6.14
Upside
+344.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Jan 13, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $48 → $2 | Strong Buy → Hold | Downgrades | $48 → $2 | +44.93% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $12 → $2 | Hold | Maintains | $12 → $2 | +44.93% | Jan 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $27 → $2.5 | Strong Buy → Hold | Downgrades | $27 → $2.5 | +81.16% | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $20 → $1.5 | Buy → Hold | Downgrades | $20 → $1.5 | +8.70% | Jan 10, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $21 → $2 | Buy → Hold | Downgrades | $21 → $2 | +44.93% | Jan 10, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $21 | Buy | Initiates | $21 | +1,421.74% | Dec 6, 2024 |
| Stifel | Stifel | Strong Buy Maintains $25 → $27 | Strong Buy | Maintains | $25 → $27 | +1,856.52% | Nov 11, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +1,349.28% | Oct 18, 2024 |
| Wedbush | Wedbush | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +1,494.20% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +1,131.88% | Oct 1, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $12 → $9 | Hold → Sell | Downgrades | $12 → $9 | +552.17% | Oct 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +769.57% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +697.10% | Sep 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +1,639.13% | Aug 23, 2024 |
| Wedbush | Wedbush | Buy Maintains $20 → $25 | Buy | Maintains | $20 → $25 | +1,711.59% | Aug 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.